Literature DB >> 27313069

Improved Behavior and Neuropsychological Function in Children With ROHHAD After High-Dose Cyclophosphamide.

Lisa A Jacobson1, Shruti Rane2, Lisa J McReynolds3, Diana A Steppan3, Allen R Chen3, Ido Paz-Priel3.   

Abstract

Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation (ROHHAD) is a rare, generally progressive, and potentially fatal syndrome of unclear etiology. The syndrome is characterized by normal development followed by a sudden, rapid hyperphagic weight gain beginning during the preschool period, hypothalamic dysfunction, and central hypoventilation, and is often accompanied by personality changes and developmental regression, leading to substantial morbidity and mortality. We describe 2 children who had symptomatic and neuropsychological improvement after high-dose cyclophosphamide treatment. Our experience supports an autoimmune pathogenesis and provides the first neuropsychological profile of patients with rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation.
Copyright © 2016 by the American Academy of Pediatrics.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27313069      PMCID: PMC4925071          DOI: 10.1542/peds.2015-1080

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  19 in total

1.  Cyclophosphamide for rapid-onset obesity, hypothalamic dysfunction, hypoventilation, and autonomic dysregulation syndrome.

Authors:  Ido Paz-Priel; David W Cooke; Allen R Chen
Journal:  J Pediatr       Date:  2010-08-21       Impact factor: 4.406

2.  The Purdue pegboard; norms and studies of reliability and validity.

Authors:  J TIFFIN; E J ASHER
Journal:  J Appl Psychol       Date:  1948-06

3.  Intrathecal synthesis of oligoclonal bands in rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation syndrome: new evidence supporting immunological pathogenesis.

Authors:  Stefano Sartori; Elena Priante; Andrea Pettenazzo; Piero Marson; Agnese Suppiej; Franca Benini; Giorgio Perilongo; Irene Toldo
Journal:  J Child Neurol       Date:  2013-01-04       Impact factor: 1.987

4.  ROHHADNET syndrome presenting as major behavioral changes in a 5-year-old obese girl.

Authors:  Karen Sethi; Yi-Horng Lee; L Eugene Daugherty; Andrea Hinkle; Mahlon D Johnson; Philip J Katzman; John S Sullivan
Journal:  Pediatrics       Date:  2014-07-21       Impact factor: 7.124

5.  Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation: analysis of hypothalamic and autonomic candidate genes.

Authors:  Casey M Rand; Pallavi P Patwari; Ekaterina A Rodikova; Lili Zhou; Elizabeth M Berry-Kravis; Richard J A Wilson; Torben Bech-Hansen; Debra E Weese-Mayer
Journal:  Pediatr Res       Date:  2011-10       Impact factor: 3.756

Review 6.  Intensive immunosuppression with high dose cyclophosphamide but without stem cell rescue for severe autoimmunity: advantages and disadvantages.

Authors:  Robert A Brodsky; Richard J Jones
Journal:  Autoimmunity       Date:  2008-12       Impact factor: 2.815

7.  Delineation of late onset hypoventilation associated with hypothalamic dysfunction syndrome.

Authors:  Loic De Pontual; Delphine Trochet; Sophie Caillat-Zucman; Othman A Abou Shenab; Pierre Bougneres; Yanick Crow; Steve Cunningham; Blandine Esteva; Lada Cindro Heberle; Juliane Leger; Graziella Pinto; Michel Polak; Magdy Helmy Shafik; Christian Straus; Ha Trang; Arnold Munnich; Stanislas Lyonnet; Isabelle Desguerre; Jeanne Amiel
Journal:  Pediatr Res       Date:  2008-12       Impact factor: 3.756

Review 8.  Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation: review and update.

Authors:  Pallavi P Patwari; Lisa F Wolfe
Journal:  Curr Opin Pediatr       Date:  2014-08       Impact factor: 2.856

9.  A case of rapid-onset obesity with hypothalamic dysfunction, hypoventilation, autonomic dysregulation, and neural crest tumor: ROHHADNET syndrome.

Authors:  Ayhan Abaci; Gonul Catli; Erhan Bayram; Tolga Koroglu; Hatice Nur Olgun; Kamer Mutafoglu; Ayse Semra Hiz; Handan Cakmakci; Ece Bober
Journal:  Endocr Pract       Date:  2013 Jan-Feb       Impact factor: 3.443

10.  Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation presenting in childhood.

Authors:  Diego Ize-Ludlow; Juliette A Gray; Mark A Sperling; Elizabeth M Berry-Kravis; Jeff M Milunsky; I Sadaf Farooqi; Casey M Rand; Debra E Weese-Mayer
Journal:  Pediatrics       Date:  2007-07       Impact factor: 7.124

View more
  7 in total

Review 1.  Autoimmunity Related to Adipsic Hypernatremia and ROHHAD Syndrome.

Authors:  Akari Nakamura-Utsunomiya
Journal:  Int J Mol Sci       Date:  2022-06-21       Impact factor: 6.208

2.  Pulmonary hypertension and chronic hypoventilation in ROHHAD syndrome treated with average-volume assured pressure support.

Authors:  Robert C Stowe; Olufunke Afolabi-Brown
Journal:  Pediatr Investig       Date:  2019-12-21

3.  Thoracic Ganglioneuroma Presenting with Paraneoplastic Cerebellitis and ROHHAD-NET Syndrome.

Authors:  Sarbesh Tiwari; Mufeed Arimbrakkunnan; Taruna Yadav; Varuna Vyas; Kirti K Rathod; Vikarn Vishwajeet
Journal:  Ann Indian Acad Neurol       Date:  2022-02-08       Impact factor: 1.714

4.  Rapid-Onset Obesity with Hypoventilation, Hypothalamic, Autonomic Dysregulation, and Neuroendocrine Tumors (ROHHADNET) Syndrome: A Systematic Review.

Authors:  Jiwon M Lee; Jaewon Shin; Sol Kim; Heon Yung Gee; Joon Suk Lee; Do Hyeon Cha; John Hoon Rim; Se-Jin Park; Ji Hong Kim; Ahmet Uçar; Andreas Kronbichler; Keum Hwa Lee; Jae Il Shin
Journal:  Biomed Res Int       Date:  2018-11-21       Impact factor: 3.411

5.  Case Report: COVID-19-Associated ROHHAD-Like Syndrome.

Authors:  Irina N Artamonova; Natalia A Petrova; Natalia A Lyubimova; Natalia Yu Kolbina; Alexander V Bryzzhin; Alexander V Borodin; Tatyana A Levko; Ekaterina A Mamaeva; Tatiana M Pervunina; Elena S Vasichkina; Irina L Nikitina; Anna M Zlotina; Alexander Yu Efimtsev; Mikhail M Kostik
Journal:  Front Pediatr       Date:  2022-03-31       Impact factor: 3.418

6.  ZSCAN1 Autoantibodies Are Associated with Pediatric Paraneoplastic ROHHAD.

Authors:  Caleigh Mandel-Brehm; Leslie A Benson; Baouyen Tran; Mark P Gorman; Joseph L DeRisi; Andrew F Kung; Sabrina A Mann; Sara E Vazquez; Hanna Retallack; Hannah A Sample; Kelsey C Zorn; Lillian M Khan; Lauren M Kerr; Patrick L McAlpine; Lichao Zhang; Frank McCarthy; Joshua E Elias; Umakanth Katwa; Christina M Astley; Stuart Tomko; Josep Dalmau; William W Seeley; Samuel J Pleasure; Michael R Wilson
Journal:  Ann Neurol       Date:  2022-05-25       Impact factor: 11.274

7.  ROHHAD syndrome without rapid-onset obesity: A diagnosis challenge.

Authors:  Blandine Desse; Antoine Tran; Mathilde Butori; Sarah Marchal; Michael Afanetti; Sébastien Barthélemy; Etienne Bérard; Elisabeth Baechler; Stéphane Debelleix; Marie-Emilie Lampin; Julie Macey; Bruno Massenavette; Julie Harvengt; Ha Trang; Lisa Giovannini-Chami
Journal:  Front Pediatr       Date:  2022-08-31       Impact factor: 3.569

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.